Gülen Hatemi Selected Research

Oral Ulcer (Mouth Ulcer)

1/2022	Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
9/2021	Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
8/2021	An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet's syndrome.
11/2019	Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
11/2019	One year in review 2019: Behçet's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gülen Hatemi Research Topics

Disease

5	Oral Ulcer (Mouth Ulcer) 01/2022 - 11/2019
3	Pain (Aches) 01/2022 - 08/2021
2	Ulcer 01/2022 - 08/2021
2	Uveitis 01/2022 - 11/2019
2	Headache (Headaches) 09/2021 - 11/2019
2	Nausea 09/2021 - 11/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Diarrhea 11/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019
1	Inflammation (Inflammations) 01/2019
1	Neoplasms (Cancer) 07/2012
1	Thrombosis (Thrombus) 07/2012
1	Philadelphia Chromosome 07/2012
1	Proctitis 01/2012

Drug/Important Bio-Agent (IBA)

5	apremilastIBA 01/2022 - 11/2019
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	Biological ProductsIBA 11/2019
1	Adalimumab (Humira)FDA Link 11/2019
1	Infliximab (Remicade)FDA Link 11/2019
1	ChemokinesIBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	CytokinesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Janus Kinase 2IBA 07/2012

Therapy/Procedure

2	Therapeutics 11/2019 - 01/2012